Australis Scientific raises US$6m for overactive bladder relief technology

Australis Scientific has secured US$6 million ($9.3 million) from Japanese healthcare giant Rohto Pharmaceutical to back development of its neuromodulation technology that alleviates symptoms of overactive bladder (OAB) – a condition that affects more than 400 million people worldwide.

The…


Click here to view the original article.